Full Breakdown
Senate Committee Hears Trump Nominee Erica Schwartz for CDC Directorship
7/15/2026, 9:26:37 PM
Core Event
On July 15, 2026, the Senate Health, Education, Labor and Pensions (HELP) Committee convened to consider President Donald Trump’s nomination of Dr. Erica Schwartz as director of the Centers for Disease Control and Prevention (CDC). The hearing focused on Schwartz’s qualifications, her stance on vaccines, and her ability to lead an agency that has endured extensive staff losses, leadership turnover, and high-profile outbreaks.
Background & Context
The CDC has experienced a revolving-door leadership crisis since President Trump returned to office in 2025. Former nominees Dr. Dave Weldon and Susan Monarez failed to secure or retain confirmation, and acting director Dr. Jay Bhattacharya of the National Institutes of Health has overseen the agency since February 2026. Internal emails released by Sen. Bernie Sanders reveal that Monarez’s brief tenure was marked by political reviews of policy decisions and cuts that eliminated more than 3,000 staff—over a quarter of the workforce. The agency now confronts the nation’s worst measles resurgence in three decades and an expanding Ebola outbreak in the Democratic Republic of Congo and Uganda.
Key Figures & Groups
- Dr. Erica Schwartz – Retired rear admiral in the U.S. Public Health Service, former Coast Guard chief medical officer and deputy surgeon general (2019-2021).
- Sen. Bill Cassidy – Republican chair of the HELP Committee, physician, and vocal advocate for vaccine science.
- Robert F. Kennedy Jr. – Secretary of Health and Human Services, former anti-vaccine activist now overseeing the CDC.
- Sean Slovenski – Deputy director and chief operating officer of the CDC, former Walmart executive.
- Dr. Marcus Plescia – District health director for Fulton County, Georgia.
Data & Statistics
- Staff reductions of >3,000 employees represent >25 % of the CDC workforce.
- Measles cases have risen to the highest level in 30 years, driven by declining childhood immunization rates.
- The Ebola response in Central Africa is among the largest on record, prompting activation of the CDC’s highest-level emergency operations.
Why It Matters
Stability at the CDC is critical for coordinated national responses to infectious-disease threats, vaccine confidence, and public-health communication. The nominee’s ability to operate independently of HHS Secretary Kennedy will shape the agency’s scientific integrity and its capacity to address ongoing outbreaks.
Official Statements & Responses
- Schwartz (opening remarks): Emphasized that “public health is in my DNA” and pledged to restore trust through “radical transparency and unwavering scientific integrity.”
- Cassidy (questioning): Asserted that “vaccines are overwhelmingly safe and effective… study after study shows they do not cause autism,” and warned that the CDC must not be swayed by “crazy, stupid things being said that undermine faith in immunization.”
- Kennedy (prior support): Stated he would not commit to accepting all of Schwartz’s vaccine decisions, leaving her autonomy ambiguous.
- Sean Kaufman (ASPR nominee): Distanced himself from past anti-vaccine comments, affirming that “vaccines save lives” and that he intends to “accelerate the development of medical countermeasures.”
Criticism & Opposition
Public-health experts caution that Kennedy’s history of challenging established vaccine schedules could limit Schwartz’s independence. Dr. Amesh Adalja of the Infectious Diseases Society of America warned that continued political influence might force the director to “do something that’s wrong.” Former CDC acting director Dr. Richard Besser expressed concern that Schwartz could be pressured to align with the secretary’s agenda, noting past dismissals of directors who resisted political directives.
Verbatim Quotes
- “Public health is in my DNA,” — Erica Schwartz, nominee
- “If confirmed, my first priority will be restoring trust in public health institutions through radical transparency and unwavering scientific integrity,” — Erica Schwartz, nominee
- “Vaccines are overwhelmingly safe and effective. They have saved countless lives. Study after study shows they do not cause autism, whether given at birth or whether given later in life,” — Bill Cassidy, Senator
- “I've heard a lot … from people about what the morale is like here, how we've gotten to a point where it's not as happy as it used to be, the stress level's extremely high,” — Sean Slovenski, CDC deputy director
- “I was very pleased to see Dr. Schwartz nominated to be the next director of the CDC,” — Richard Besser, former CDC acting director
Conflicting Reports & Gaps
- Kennedy’s public statements suggest limited oversight, yet internal emails indicate a “political review” mandate for major CDC policies.
- While Schwartz declined to answer directly on exerting authority over the agency, she affirmed that the secretary “will absolutely allow me to be CDC director,” leaving the extent of her operational independence unclear.
What’s Next
The HELP Committee will vote on Schwartz’s nomination later this week before forwarding the recommendation to the full Senate for confirmation. Senators are expected to probe further on vaccine policy autonomy and the agency’s restructuring plans.
